Long-Awaited CLIA Waiver Guidance To Be Issued Mid-Year – FDA
This article was originally published in The Gray Sheet
Executive Summary
Outgoing Clinical Laboratory Improvement Advisory Committee Chair David Sundwall, MD, is pressing FDA to expedite publication of the agency's CLIA-waiver guidance